MRI in lung cancer: A pictorial essay

British Journal of Radiology

Volumn 84, Issue 1003, 2011, Pages 661-668

  Hochhegger, Bruno ^a   Marchiori, E ^b   Sedlaczek, O ^c   Irion, K ^d   Heussel, C P ^b   Ley, S ^b   Ley Zaporozhan, J ^b   Soares Souza Jr , A ^e   Kauczor, H U ^b  

^a Santa Casa de Porto Alegre   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^e Sao Jose do Rio Preto Medical School   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFUSION TENSOR IMAGING; HUMAN; LUNG BIOPSY; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; TUMOR VOLUME;

FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79959620668     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/24661484     Document Type: Review

References (18)

1. Husband J, Padhani A. The Royal College of Radiologists. Recommendations for cross-sectional imaging in cancer management (August 2006). Available from: http://www.rcr.ac.uk/docs/oncology/pdf/Cross-Sectional-Imaging-12.pdf.
2. Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-13.
3. Ohno Y, Hatabu H, Takenaka D, Higashino T, Watanabe H, Ohbayashi C, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 2004;231:872-9. (Pubitemid 38668111)
4. Biederer J. General requirements of MRI of the lung and suggested standard protocols. In: Kauczor HU, ed. MRI of the lung. Heidelberg, Springer-Verlag Berlin. 2009: pp 3-16.
5. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400. (Pubitemid 41507873)
6. Koyama H, Ohno Y, Kono A, Takenaka D, Maniwa Y, Nishimura Y, et al. Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in161 subjects. Eur Radiol 2008;18:2120-31.
7. Ohno Y, Koyama H, Dinkel J, Hintze C. Lung cancer. In: Kauczor HU, ed. MRI of the lung. Heidelberg, Springer-Verlag Berlin. 2009: pp 179-216.
8. International Association for the Study of Lung Cancer. IASLC staging manual in thoracic oncology. Orange Park, FL: Editorial RX Press; 2009.
9. Ohno Y, Adachi S, Motoyama A, Kusumoto M, Hatabu H, Sugimura K, et al. Multiphase ECG triggered 3D contrast-enhanced MR angiography: utility for evaluation of hilar and mediastinal invasion of bronchogenic carcinoma. J Magn Reson Imaging 2001;13:215-24. (Pubitemid 32066658)
10. Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, et al. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. J Magn Reson Imaging 2007;26:1071-80. (Pubitemid 47548169)
11. Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V. Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. Lung Cancer 2008;60:62-8. (Pubitemid 351434459)
12. Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 2008;248:632-42.
13. Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 2005;40:743-53. (Pubitemid 41690430)
14. Lee HY, Lee KS, Kim BT, Cho YS, Lee EJ, Yi CA, et al. Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma. J Korean Med Sci 2009;24:1132-8.
15. Gallagher FA. An introduction to functional and molecular imaging with MRI. Clin Radiol 2010;65:557-66.
16. Qi LP, Zhang XP, Tang L, Li J, Sun YS, Zhu GY. Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study. Eur Radiol 2009;9:333-41.
17. Nakayama J, Miyasaka K, Omatsu T, Onodera Y, Terae S, Matsuno Y, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 2010;34:1-8.
18. Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment - utility for wholebody diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008;248:643-54.